ANI Pharmaceuticals
ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Baudette, Minnesota, that develops, manufactures, and markets both branded and generic prescription pharmaceuticals primarily in the United States and Canada. The company focuses on producing a diverse range of products, including controlled substances, oncolytics, hormones, and steroids, catering to various medical conditions such as cancer, hypertension, depression, and pain management. ANI manufactures oral solid dose products, liquids, and topical formulations, including potent drugs that require specialized manufacturing environments. Additionally, the company engages in contract manufacturing for other pharmaceutical firms. With a commitment to quality, ANI's products are distributed through various channels, including retail pharmacies, wholesalers, and mail-order services. Founded in 2001, ANI Pharmaceuticals has established itself as a significant player in the pharmaceutical industry, contributing to the treatment of various health issues through its extensive product offerings.
Novitium Pharma is a pharmaceutical company that specializes in development, manufacturing, and distribution of niche generic products. It developed a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. Novitium continues to invest in producing affordable, high-quality medication to fulfill the needs of pharmacists, patients, and communities.
Since 2001, WellSpring Pharma Services has established itself as a leading pharmaceutical contract manufacturing organization by emphasizing quality, precision and constant improvement. Today, WellSpring provides pharmaceutical manufacturing services for virtually all non-sterile finished dosage form products, such as of solids, semisolids and oral liquids and suspensions, as well as primary and secondary packaging in a variety of presentations. WellSpring adheres to strict cGMP standards and has an excellent audit history with the US Food and Drug Administration (FDA) and Health Canada.
BioSante Pharmaceuticals, Inc. (BioSante) is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. The Company's products for female sexual health, menopause, contraception and male hypogonadism include LibiGel, a once daily transdermal testosterone gel in Phase III clinical development under a special protocol assessment (SPA) for the treatment of female sexual dysfunction (FSD); Elestrin, a once daily transdermal estradiol (estrogen) gel indicated for the treatment of moderate-to-severe vasomotor symptoms; The Pill-Plus (triple component contraceptive), a once daily use of various combinations of estrogens, progestogens and androgens in development for the treatment of female sexual dysfunction (FSD) in women using oral or transdermal contraceptives, and Bio-T-Gel, a once daily transdermal testosterone gel in development for the treatment of hypogonadism, or testosterone deficiency, in men.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.